Your session is about to expire
← Back to Search
Early Brain Surgery for Brain Tumor
N/A
Recruiting
Led By Terence C Burns
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Histological or cytological confirmation of brain tumor and/or suspected brain tumor based on clinical and radiologic findings
Age >= 18 years
Must not have
Avastin within the past 6 months for any reason
Age < 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether surgery on brain tumors before they come back is more effective than surgery at a different time or no surgery.
Who is the study for?
This trial is for adults over 18 who've had chemo or radiation for brain tumors but still have some tumor left. They must be willing to undergo surgery, not be pregnant or unable to consent, and can't have had a complete tumor removal before. They should also not qualify for other clinical trials.
What is being tested?
The study looks at the timing of brain surgery in treating tumors that haven't recurred yet. It compares outcomes between those having early surgery after chemo/radiation and those who wait or don’t get operated on at all.
What are the potential side effects?
Potential side effects include typical risks associated with brain surgery such as infection, bleeding, neurological damage, reaction to anesthesia, and complications from wound healing.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My brain tumor diagnosis was confirmed through lab tests or imaging.
Select...
I am 18 years old or older.
Select...
I have had chemotherapy or radiation for my tumor.
Select...
I am willing to have surgery and understand the risks involved.
Select...
I have tumors that haven't been removed or still show on scans.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have not taken Avastin in the last 6 months.
Select...
I am under 18 years old.
Select...
I am considered vulnerable due to pregnancy or inability to consent.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Feasibility of surgical resection by short and long term outcomes
Incidence of adverse events
Secondary study objectives
Neurosurgical morbidity
Overall survival
Progression free survival
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Treatment (surgery)Experimental Treatment1 Intervention
Patients undergo surgery as indicated clinically when applicable.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,343 Previous Clinical Trials
3,062,309 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,928 Previous Clinical Trials
41,017,998 Total Patients Enrolled
Terence C BurnsPrincipal InvestigatorMayo Clinic in Rochester
4 Previous Clinical Trials
391 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am considered at high risk for surgery complications by my surgeon.I had surgery to completely remove a brain tumor, and no visible disease remains.I have not taken Avastin in the last 6 months.My brain tumor diagnosis was confirmed through lab tests or imaging.I am 18 years old or older.I have had chemotherapy or radiation for my tumor.I am willing to have surgery and understand the risks involved.I haven't had surgery or radiation but could join another trial for my condition.I have tumors that haven't been removed or still show on scans.I am under 18 years old.I am considered vulnerable due to pregnancy or inability to consent.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment (surgery)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger